Compare ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund vs SBI Healthcare Opportunities Fund
Risk | Very High | Very High |
Rating | 5.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.86 | 1.94 |
NAV | ₹37.51 | ₹403.64 |
Fund Started | 25 Jun 2018 | 04 Jun 1999 |
Fund Size | ₹6455.55 Cr | ₹3989.42 Cr |
Exit Load | Exit load of 1% if redeemed within 15 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
5.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.86
1.94
NAV
₹37.51
₹403.64
Fund Started
25 Jun 2018
04 Jun 1999
Fund Size
₹6455.55 Cr
₹3989.42 Cr
Exit Load
Exit load of 1% if redeemed within 15 days.
Exit load of 0.50% if redeemed within 15 days
1 Year | -1.13% | -3.88% |
3 Year | 25.33% | 22.21% |
5 Year | 16.15% | 14.98% |
1 Year
-1.13%
-3.88%
3 Year
25.33%
22.21%
5 Year
16.15%
14.98%
Equity | 97.87% | 96.59% |
Cash | 2.13% | 3.34% |
Equity
97.87%
96.59%
Cash
2.13%
3.34%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.05% |
Cipla Ltd. | 7.90% |
Dr. Reddy's Laboratories Ltd. | 7.82% |
Divi's Laboratories Ltd. | 7.10% |
Mankind Pharma Ltd. | 6.44% |
Lupin Ltd. | 5.78% |
Aurobindo Pharma Ltd. | 5.19% |
Alkem Laboratories Ltd. | 3.66% |
Cohance Lifesciences Ltd. | 3.01% |
Syngene International Ltd. | 2.98% |
Sun Pharmaceutical Industries Ltd. | 11.64% |
Divi's Laboratories Ltd. | 7.05% |
Max Healthcare Institute Ltd. | 5.24% |
Lupin Ltd. | 4.44% |
Laurus Labs Ltd. | 3.89% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Acutaas Chemicals Ltd. | 3.85% |
Cipla Ltd. | 3.79% |
Lonza Group Ag | 3.63% |
Biocon Ltd. | 3.16% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 25 Jun 2018 | 04 Jun 1999 |
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
25 Jun 2018
04 Jun 1999